An open-label, non-comparative, non-interventional, multi-center, post-authorization safety study on the administration of rabeprazole to adults with gastro-esophageal reflux disease

BACKGROUND: Rabeprazole produces a profound and long-lasting inhibition of gastric acid secretion. The aim of the study was to monitor the safety and efficacy of rabeprazole administered to patients with erosive or symptomatic non-erosive reflux disease, in real-life healthcare settings. METHODS: Ma...

Descripción completa

Detalles Bibliográficos
Autores principales: Zouboulis-Vafiadis, Irini, Paraskevas, Emmanuel, Tzourmakliotis, Dimitrios, Hatzikyriakou, Maria, Mestoussi, Angeliki, Vasdekis, Vassilios, Katsilabros, Nikolaos, Arhimandritis, Athanasios, Papadokostopoulou, Alexandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hellenic Society of Gastroenterology 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3982628/
https://www.ncbi.nlm.nih.gov/pubmed/24732963

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3982628/
https://www.ncbi.nlm.nih.gov/pubmed/24732963

Ejemplares similares